Lunai Bioworks Inc. (LNAI)
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Lunai Bioworks Inc.
OTC:LNAIOTC (delisted from Nasdaq, Form 25 effective Nov 12, 2026)Healthcare · Biotechnology
Mkt Cap$830K
EV-
Float4.88M
O/S5.03M
VOL1.27M sh
$ Vol$195K
RVOL0.86×
Inst Own3.8%
SI0.4%
Net Cash/Sh-
Dilution
MCap$830KFloat4.88MO/S5.03M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | 0.2290 | 0.2300 | 0.1410 | 0.1648 | 1,275,391 |
| Oct 28, 2026 | 0.2211 | 0.2500 | 0.2023 | 0.2361 | 622,776 |
| Oct 27, 2026 | 0.2576 | 0.2699 | 0.2403 | 0.2525 | 521,332 |
| Oct 26, 2026 | 0.2629 | 0.3016 | 0.2327 | 0.2750 | 620,807 |
| Oct 23, 2026 | 0.2600 | 0.3156 | 0.2265 | 0.2946 | 9,584,097 |
| Oct 22, 2026 | 0.5300 | 0.5300 | 0.4601 | 0.4700 | 174,309 |
| Oct 21, 2026 | 0.4995 | 0.5445 | 0.4995 | 0.5180 | 90,439 |
| Oct 20, 2026 | 0.4900 | 0.5798 | 0.4720 | 0.5150 | 218,625 |
| Oct 19, 2026 | 0.6952 | 0.6952 | 0.4615 | 0.4720 | 205,222 |
| Oct 16, 2026 | 0.8122 | 0.8122 | 0.6602 | 0.6804 | 79,860 |
| Oct 15, 2026 | 0.8654 | 0.9172 | 0.8177 | 0.8255 | 37,877 |
| Oct 14, 2026 | 0.9991 | 1.01 | 0.8922 | 0.8922 | 69,619 |
| Oct 13, 2026 | 1.09 | 1.09 | 1.01 | 1.03 | 50,362 |
| Oct 12, 2026 | 1.29 | 1.29 | 1.05 | 1.11 | 97,191 |
| Oct 9, 2026 | 1.17 | 1.68 | 0.8757 | 1.23 | 858,870 |
| Oct 8, 2026 | 1.14 | 1.15 | 1.10 | 1.12 | 14,852 |
| Oct 7, 2026 | 1.19 | 1.19 | 1.08 | 1.09 | 19,979 |
| Oct 6, 2026 | 1.13 | 1.20 | 1.13 | 1.13 | 23,645 |
| Oct 5, 2026 | 1.25 | 1.30 | 1.14 | 1.14 | 69,260 |
| Oct 2, 2026 | 1.44 | 1.46 | 1.23 | 1.30 | 124,972 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
3.8%
Institutional
(17)
0.1%
Insiderⓘ
(2)
16.5%
5%+ Owners
(4)
of which 6.5% rests on schedules older than 24 months (2 holders)
79.6%
Unattributed (incl. retail)ⓘ
Institutional3.8%
Insider0.1%
5%+ Beneficial16.5%
Unattributed (incl. retail)79.6%
Top Shareholders
| Name | Shares | % | Source |
|---|---|---|---|
Laksya Ventures Inc. · may incl. warrants· filed Sep 2025 | 277.1K | 5.5% | 13G |
William Anderson Wittekind · may incl. warrants· filed Oct 2026 | 226.7K | 4.5% | 13D |
Rene Sindlev · may incl. warrants· stale · filed Feb 2024 | 186.8K | 3.7% | 13D |
Paseco ApS · may incl. warrants· stale · filed Feb 2024 | 139.5K | 2.8% | 13G |
VANGUARD CAPITAL MANAGEMENT LLC | 50.0K | 1.0% | 13F |
GEODE CAPITAL MANAGEMENT, LLC | 41.5K | 0.8% | 13F |
STATE STREET CORP | 37.5K | 0.7% | 13F |
JANE STREET GROUP, LLC | 21.6K | 0.4% | 13F |
BlackRock, Inc. | 15.9K | 0.3% | 13F |
UBS Group AG | 12.2K | 0.2% | 13F |
Sources: 13F, Form 4, 13D/13GO/S: 5.0M · as of 13 Oct 2026 · SEC filings
Insiders & Institutional Holders
Insiders
- van Tilburg MauriceDirector
- Weinstein David HershelChief Executive Officer, Director
About
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Key Metrics
Market Cap$829,678
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership3.79%
based on 5.03M shares outstanding
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
Country
US
IPO DateSep 30, 2025
Shares Outstanding5.03M
Authorized Shares
Float4.88M
SEC Float (non-affiliate)4.97M
52-Week Range
Volume
Average Daily Volume1.48M
30d Avg
1.48M
60d Avg
529.20K
90d Avg
320.68K
Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...
Signal8's dilution snapshot of LNAI as of Jun 30, 2026 records 3 outstanding warrant series and an offering priced Sep 2, 2026, from SEC filings. Lunai Bioworks Inc. (OTC: LNAI) is in the Healthcare sector (Biotechnology).